Tissue Plasminogen Activator (tPA) Inhibits Human Neutrophil Superoxide Anion Production in Vitro

Author： Stringer Kathleen A.   Lindenfeld Joann   Repine Alexander J.   Cohen Zoe   Repine John E.  

Publisher： Springer Publishing Company

ISSN： 0360-3997

Source： Inflammation, Vol.21, Iss.1, 1997-02, pp. : 27-34

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tissue plasminogen activator (tPA) antigen in plasma: correlation with different tPA/inhibitor complexes

By Nordenhem A   Wiman B  

Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 58, Iss. 6, 1998-10 ,pp. : 475-484

Informa Healthcare

Access to resources Recommend Favorite

Nattokinase-Promoted Tissue Plasminogen Activator Release from Human Cells

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 36, Iss. 5, 2009-12 ,pp. : 227-232

Karger

Access to resources Recommend Favorite

Successful treatment of pediatric stroke with recombinant tissue plasminogen activator (rt-PA): a case report and review of the literature

By  

Canadian Journal of Emergency Medicine, Vol. 10, Iss. 6, 2008-11 ,pp. : 575-578

Cambridge University Press

Access to resources Recommend Favorite

Recombinant tissue plasminogen activators (rtPA): A review

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 97, Iss. 3, 2015-03 ,pp. : 274-285

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effect of prostaglandin E2 on urokinase-type plasminogen activator production by human lung fibroblasts

By Odaka Tomotada   Kobayashi Katsuyuki   Takahashi Kimiko   Nakamura Hiroyuki   Matsuoka Takeshi  

Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 69, Iss. 2, 2009-04 ,pp. : 225-233

Informa Healthcare

Access to resources Recommend Favorite